Articles

Page 8 of 19

Syphilis infection is associated with an increase in plasma viral load in HIV infected patients: results from the FHDH cohort — ANRS CO4

Authors: W Jarzebowski, C Piketty, P de Truchis, E Caumes, D Farhi, AS Lascaux, MA Bouldouyre, O Derradji, J Pacanowski, N Dupin, D Costagliola and S Grabar

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P223

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Efficacy and safety of TMC278 in treatment-naïve, HIV-1-infected patients with HBV/HCV co-infection enrolled in the phase III ECHO and THRIVE trials

Authors: M Nelson, G Amaya, N Clumeck, C Arns Da Cunha, D Jayaweera, P Junod, L Taisheng, P Tebas, M Stevens, A Buelens, S Vanveggel and K Boven

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P210

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy

Authors: P Labarga, ME Vispo, JM Guardiola, C Miralles, L Martín-Carbonero, J Portu, P Barreiro, P Miralles, J Morello, MJ Tellez, P Bancalero, V Asensi, NI Rallón, I Santos, L Morano, K Aguirrebengoa…

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P208

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Opportunistic infections (OIs) present in HIV-seropositive patients: a study

Authors: K Ayodhya Ramaiah, B Sudha Rani, R Anand, S Ramola, P Satish Babu and R Ramesh Babu

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P191

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Herb-drug interaction between Echinacea purpurea and darunavir/ritonavir in HIV-infected patients

Authors: J Moltó, M Valle, C Miranda, S Cedeño, E Negredo, MJ Barbanoj and B Clotet

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P187

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Minority M184V variants in women exposed to 3TC/FTC-containing lopinavir-ritonavir (LPVr) regimens in pregnancy

Authors: S Surah, S Oshea, S Costelloe, M Hanlon, J Mullen, I Chrystie, GP Taylor and A De Ruiter

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P159

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Evaluating pharmacist involvement in HIV outpatient clinics: can medication histories, drug interaction checks and adherence assessments add benefit?

Authors: K Seden, DJ Back and SH Khoo

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P115

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Safety and efficacy of maraviroc (MVC) combined with multiple different therapeutic agents in highly treatment-experienced (TE) patients in Brazil

Authors: JJD Furtado, JV Madruga, EL Bicudo, M Eira, MIB Lopes, EM Netto, MS de Oliveira, OHM Leite, AA Machado, U Tupinambas, JL de Andrade Neto, MPJ Lima, DB Wajsbrot and LM Cassoli

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P105

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial)

Authors: I Izzo, L Albini, A Calabresi, D Motta, R Bellagamba, R Fezza, P Narciso, L Sighinolfi, P Maggi, E Focà, M Mendeni, L Manili, M Magoni, G Carosi, E Quiros-Roldan and C Torti

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P85

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Smoking, female gender and PI use are associated with decreasing renal function in TDF-containing HAART

Authors: A Uglietti, C Gervasoni, E Gabrielli, S Di Giambenedetto, R Cauda, R Esposito, P Grima, G Di Perri, R Maserati and M Galli

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P84

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDA

Authors: L Ryom, A Mocroft, P Reiss, B Ledergerber, S De Wit, D Duiculescu, AD Monforte, M Murphy, JD Lundgren and O Kirk

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P82

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years

Authors: D Podzamczer, JM Tiraboschi, J Mallolas, MA Cárdenes, E Casas, A Castro, S Echevarria, M Leal, JC Lopez Bernanldo de Quirós, S Moreno, T Puig, E Ribera, C Villalonga, JL Gomez Sirvent, JA Garcia Heranejos, J Lopez-Aldeguer…

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P81

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Switching to nevirapine (NVP) significantly increases high-density lipoprotein cholesterol (HDL-C) in treatment-experienced patients (NEVICOR study)

Authors: JM Rodriguez, M Delgado, P Viciana, MA Lopez-Ruz, M Leal, F Alcacer, E Deig, A Antela, E Pedrol and S Moreno

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P79

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir

Authors: T Overton, JA Aberg, S Gupta, R Ryan, B Baugh and G De La Rosa

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P74

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Hypertriglyceridemic waist identifies HIV+ men and women at increased cardiometabolic risk

Authors: G Guaraldi, S Zona, G Orlando, F Carli, C Stentarelli, J Despres and R Ross

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P73

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Long-term efficacy and safety of low-dose ritonavir-boosted atazanavir (ATV/r) 200/100 mg in HIV-infected Thai patients

Authors: A Avihingsanon, T Apornpong, SJ Kerr, J Ananworanich and K Ruxrungtham

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P60

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Prediction of virological failure in HIV-infected individuals treated with cART in Suriname

Authors: MP Bleijenberg, WFW Bierman, C Jaglall, MW Heymans, MC ten Doesschate, PT Nieuwkerk, PH Smits, M van Eer and S Vreden

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P56

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)

Authors: J Eron, JM Livrozet, P Morlat, A Lazzarin, C Katlama, T Hawkins, T Fujiwara, R Cuffe, C Vavro, J Santiago, M Ait-Khaled, S Min and JM Yeo

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O51

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Once-daily S/GSK1349572 combination therapy in antiretroviral-naïve adults: rapid and potent 24-week antiviral responses in SPRING-1 (ING112276)

Authors: J Rockstroh, F Felizarta, F Maggiolo, F Pulido, HJ Stellbrink, O Tsybakova, P Yeni, S Almond, C Brothers, I Song and S Min

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O50

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Switching from tipranavir (TPV) 500/ritonavir (RTV) 200 mg to TPV 500/RTV 100 mg in treatment-experienced patients (pts) with HIV RNA <50 copies/mL

Authors: JL Casado, P Domingo, R Rubio, A Antela, MA Lopez-Ruz, A Castro, J Portilla, E Ribera, D Podzamczer, JA Oteo, J Galindo, S Otero, F Lozano, V Estrada, J Moltó and S Moreno

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P49

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Maraviroc (MVC) increases CD4+ and CD8+ cells: long-term data from the MVC clinical development program

Authors: A Lazzarin, JG Sierra-Madero, M Battegay, G Mukwaya, R Burnside, D Chapman, J McCracken, S Portsmouth, S Valluri, H Valdez and J Heera

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O45

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART

Authors: S Rusconi, P Vitiello, F Adorni, E Colella, E Focà, AF Capetti, P Meraviglia, C Abeli, S Bonora, M D'Annunzio, A Di Biagio, A Di Pietro, L Butini, G Orofino, S Farina, G d'Ettorre…

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O44

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Tolerance and durability of abacavir/lamivudine (ABC/3TC)-containing regimens: results from a large prospective French cohort

Authors: L Cuzin, C Allavena, L Levy-Bachelot, MA Valantin, H Mellliez, P Pugliese, I Poizot-Martin, C Duvivier, L Finkielsztejn and S Abel

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P44

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study

Authors: E Martínez, JA Arranz, D Podzamczer, M Lonca, J Sanz, P Barragán, H Knobel, E Ribera, F Gutierrez, S Valero, B Clotet, D Dalmau, F Segura, JR Arribas, P Barrufet, I Santos…

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P43

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Cardiovascular risk assessment in persons with HIV in the developing world: comparing three risk equations in a cohort of HIV-infected Thais

Authors: N Edwards-Jackson, SJ Kerr, HV Tieu, J Ananworanich, SM Hammer, K Ruxrungtham, P Phanuphak and A Avihingsanon

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O40

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Long-term follow-up of HIV-infected patients in salvage therapy with raltegravir plus optimized background regimens: a multicentre Italian experience

Authors: S Landonio, P Meraviglia, AF Capetti, A Di Biagio, S Lo Caputo, G Sterrantino, A Ammassari, B Menzaghi, M Franzetti, G De Socio, G Pellicanò, E Mazzotta, P Zucchi and G Rizzardini

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P38

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Early mortality following ART initiation in HIV-infected adults and children in Uganda and Zimbabwe

Authors: AS Walker, P Mugyenyi, P Munderi, J Hakim, AA Kekitiinwa, E Katabira, CF Gilks, C Kityo, P Nahirya-Ntege, K Nathoo and D Gibb

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O37

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Long-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced HIV patients

Authors: K Jansen, A Sönnerborg, P Pugliese, S Biguenet, JL Eychenne, NH Brockmeyer, C Michalik, S Dupke, H Jaeger, A Plettenberg, D Butcher, MJ Jiménez-Expósito and HIV KompNet

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P31

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Influence of demographic and disease parameters on virological response to once- vs twice-daily darunavir/ritonavir (DRV/r) at week 48 in ODIN

Authors: M Sension, C Arns Da Cunha, P Domingo, K Supparatpinyo, T Van De Casteele, P De Doncker and F Tomaka

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P25

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Changing antiretrovirals whilst viral load <50 copies/ml and relationship with CD4 count changes

Authors: A Mocroft

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P24

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Cross-sectional study of HIV living people cohort to specify indications to antiretroviral treatment in naïve patients

Authors: AJ Pronin and GD Kaminskiy

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P23

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
0215. Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens

Authors: T Bommenel, JL Meynard, O Launay, A Simon, A Mahamat, V Martinez, J Gilquin, C Katlama, AS Lascaux, C Pradier, E Rouveix, D Costagliola and S Abgrall

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O21

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
O135. A pilot study to determine the prevalence of HIV in persons presenting for care with selected conditions: preliminary results from the HIV in Europe study

Authors: A Sönnerborg, A Mocroft, JD Lundgren, D Raben, J Gatell, A Vassilenko, V Hadziosmanovic, J Bergovac, H Sørensen, M Cusini, N Clumeck, B Gazzard, J Rockstroh, M Zuin and A D'Arminio Monforte

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O16

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
O132. Treatment-as-prevention: stopping the epidemic of HIV

Authors: B Williams

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O13

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
O124. Impact of baseline HIV-1 tropism on viral response and CD4 gains in antiretroviral-naïve patients

Authors: E Seclén, M Gonzalez, L Martín-Carbonero, H Gellermann, V Cairns, M Distel, W Kadus, V Soriano and E Poveda

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O10

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
O122. Calibration and accuracy of the geno2pheno co-receptor algorithm for predicting HIV tropism for single and triplicate measurements of V3 genotype

Authors: LC Swenson, D Knapp and PR Harrigan

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O8

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
O121. Consensus statement of the European guidelines on clinical management of HIV-1 tropism testing

Authors: LPR Vandekerckhove, AMJ Wensing, R Kaiser, F Brun-Vezinet, B Clotet, A De Luca, S Dressler, F Garcia, AM Geretti, T Klimkait, K Korn, B Masquelier, CF Perno, J Schapiro, V Soriano, A Sönnerborg…

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O7

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
O116. The EuResist expert model for customised HAART optimisation: 2010 update and extension to newest compounds

Authors: A Pironti, A Sönnerborg, M Zazzi, R Kaiser, D Struck, B Clotet, ÀM Vandamme, F Incardona, T Lengauer, M Rosen-Zvi and M Prosperi

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O6

Content type: Oral presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults

Authors: C Orkin, E DeJesus, H Khanlou, A Stoehr, K Supparatpinyo, T Van de Casteele, E Lathouwers and S Spinosa-Guzman

Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P3

Content type: Poster presentation Published on: 8 November 2010

This article is part of a Supplement: Volume 13 Supplement 4
- View Full Text
- View PDF
Cost analysis of centralized viral load testing for antiretroviral therapy monitoring in Nicaragua, a low-HIV prevalence, low-resource setting

HIV viral load testing as a component of antiretroviral therapy monitoring is costly. Understanding the full costs and the major sources of inefficiency associated with viral load testing is critical for optim...

Authors: Jay Gerlach, Magda Sequeira, Vivian Alvarado, Christian Cerpas, Angel Balmaseda, Alcides Gonzalez, Tala de los Santos, Carol E Levin, Juan Jose Amador and Gonzalo J Domingo

Citation: Journal of the International AIDS Society 2010 13:43

Content type: Research Published on: 5 November 2010
- View Full Text
- View PDF
Purging the HIV-1 reservoir through the disruption of the PD-1 pathway

Authors: S DaFonseca, N Chomont, M El Far, R Boulassel, J Routy and R Sékaly

Citation: Journal of the International AIDS Society 2010 13(Suppl 3):O15

Content type: Oral presentation Published on: 4 November 2010

This article is part of a Supplement: Volume 13 Supplement 3
- View Full Text
- View PDF
Effect of 24 weeks of intensification with a CCR5-antagonist on the decay of the HIV-1 latent reservoir

Authors: L Díaz, C Gutiérrez, C Page, R Lorente, B Hernández-Novoa, A Vallejo, E Domínguez, M Abad, N Madrid, A Moreno, MJ Pérez-Elías, R Rubio, MA Muñoz-Fernández and S Moreno

Citation: Journal of the International AIDS Society 2010 13(Suppl 3):O13

Content type: Oral presentation Published on: 4 November 2010

This article is part of a Supplement: Volume 13 Supplement 3
- View Full Text
- View PDF
Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV-1-infected patients with undetectable viremia

Authors: C Garrido, N Rallón, N Zahonero, M de la O López, V Soriano, C de Mendoza and JM Benito

Citation: Journal of the International AIDS Society 2010 13(Suppl 3):O12

Content type: Oral presentation Published on: 4 November 2010

This article is part of a Supplement: Volume 13 Supplement 3
- View Full Text
- View PDF
Changes in CD4+ cells’ miRNA expression following exposure to HIV-1

Authors: F Bignami, E Pilotti, L Bertoncelli, P Ronzi, M Gulli, N Marmiroli, G Magnani, M Pinti, C Mussini, L Lopalco, R Ruotolo, M Galli, A Cossarizza and C Casoli

Citation: Journal of the International AIDS Society 2010 13(Suppl 3):O11

Content type: Oral presentation Published on: 4 November 2010

This article is part of a Supplement: Volume 13 Supplement 3
- View Full Text
- View PDF
LEDGF/p75 is critical but not essential for multiple-round HIV 1 replication

Authors: RLG Schrijvers, J De Rijck, R Gijsbers, K Ronen, FD Bushman and Z Debyser

Citation: Journal of the International AIDS Society 2010 13(Suppl 3):O10

Content type: Oral presentation Published on: 4 November 2010

This article is part of a Supplement: Volume 13 Supplement 3
- View Full Text
- View PDF
The role of the ubiquitin-proteasome pathway in rhTRIM5α restriction of HIV-1

Authors: CM Danielson and TJ Hope

Citation: Journal of the International AIDS Society 2010 13(Suppl 3):O9

Content type: Oral presentation Published on: 4 November 2010

This article is part of a Supplement: Volume 13 Supplement 3
- View Full Text
- View PDF
Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells

Authors: VA Evans, S Saleh, EK Haddad, PU Cameron, R-P Sekaly and SR Lewin

Citation: Journal of the International AIDS Society 2010 13(Suppl 3):O7

Content type: Oral presentation Published on: 4 November 2010

This article is part of a Supplement: Volume 13 Supplement 3
- View Full Text
- View PDF
HIV-1 Tat complexes reveal subunit composition of active P-TEFb and stable association with 7SKsnRNP

Authors: B Sobhian, N Laguette, A Yatim, M Nakamura, Y Levy, R Kiernan and M Benkirane

Citation: Journal of the International AIDS Society 2010 13(Suppl 3):O5

Content type: Oral presentation Published on: 4 November 2010

This article is part of a Supplement: Volume 13 Supplement 3
- View Full Text
- View PDF
Where are macrophage-tropic viruses?

Authors: G Schnell, S Joseph, S Spudich, R Price and R Swanstrom

Citation: Journal of the International AIDS Society 2010 13(Suppl 3):O3

Content type: Oral presentation Published on: 4 November 2010

This article is part of a Supplement: Volume 13 Supplement 3
- View Full Text
- View PDF
CD4+ T cell reconstitution, T cell activation, and memory T cell subset composition in blood and gut of HIV-negative and ART-suppressed HIV-positive patients: implications for HIV persistence in the gut

Authors: S Yukl, E Sinclair, L Epling, Q Li, A Shergill, K McQuaid, L Duan, B Hare, H Lampiris, A Haase, D Havlir and J Wong

Citation: Journal of the International AIDS Society 2010 13(Suppl 3):O1

Content type: Oral presentation Published on: 4 November 2010

This article is part of a Supplement: Volume 13 Supplement 3
- View Full Text
- View PDF

How was your experience today?

Rating Please select one rating

Awful

Bad

Good

Great

Thank you for your feedback.

Tell us why (opens in a new tab)

Articles

Journal of the International AIDS Society